drugset / Trial / NCT00724256

Short-term Antibiotic Therapy for Pyelonephritis in Childhood

NCT00724256

Phase 3 Terminated 36 enrolled IRCCS Burlo Garofolo
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of oral ceftibuten for 7 days versus 10 days in acute pyelonephritis in children. The main hypothesis is that the ceftibuten for 7 days will be not inferior to ceftibuten 10 days in the rate of renal scarring at 6-12 months.

Timeline

Start
2006-07
Primary completion
2009-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftibuten Small molecule 9 mg/kg Oral

Indications